What This Report
Will Provide?
This study involved four major activities in estimating the current size of the
pcr technology market. Exhaustive secondary research was carried out to collect
information on the market, its peer markets, and its parent market.
The next step was to validate these findings, assumptions, and sizing with
industry experts across the value chain through primary research. Both top-down
and bottom-up approaches were employed to estimate the complete market size.
After that, market breakdown and data triangulation procedures were used to
estimate the size of segments and subsegments.
Expected Revenue Growth:
[193
Pages Report] The PCR
technology market is projected to reach USD 9.8 billion by 2025 from USD
7.2 billion in 2020, at a CAGR of 6.3% from 2020 to 2025.
Major Growth Boosters:
The growth of this market is
primarily driven by the rising incidences of target diseases and genetic
disorders; continuous technological advancements in PCR technologies, the
development of miniaturized portable instruments, and incorporation of
robotics; increasing investments, funds, and grants for research activities;
increasing use of biomarker profiling for disease diagnostics; and the
successful completion of the Human Genome Project.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96291811
Recent Developments in PCR Technology Market:
1. In 2020, Roche (Switzerland) announced FDA 510(k) clearance for the cobas
BKV Test on the cobas 6800 and 8800 Systems
2. In 2020, Roche (Switzerland) that the
cobas SARS-CoV-2 & Influenza A/B Test received emergency use authorization
for use on the cobas 6800/8800 Systems from the FDA
3. In 2020, Roche (Switzerland) acquired Stratos Genomics (US), an early-stage
sequencing technology company, to advance the development of Roche’s nanopore
sequencer
Asia-Pacific to Register Highest Growth in PCR Technology Market:
Healthcare infrastructure
modernization, increasing penetration of cutting-edge diagnostic technologies
(including PCR technologies) for research and clinical applications, growing
awareness among physicians and healthcare professionals about the benefits of
gene-based disease diagnosis and treatment, and the increasing public-private
support to develop novel PCR technologies in Asia Pacific countries have
accounted for a particularly high growth rate in this region.
Key
Questions Addressed in The Report:
1.
Who are the top 10 players
operating in the global PCR Technology Market?
2. What are the drivers, restraints, opportunities, and challenges in the
Industry?
3. What are the opportunities for stakeholders and provide details of the
competitive landscape for key players?
4. What will be growth of PCR Technology in North America, Europe, Asia
Pacific, Latin America, and the Middle East and Africa?
The dPCR segment is
expected to grow at the highest CAGR in the PCR technologies market. This is
due to ongoing technological developments, growing adoption of dPCR products
among key end users (compared with qPCR and other PCR products) across mature
markets, continued expansion in the distribution networks of major product
manufacturers, and growing private funding for developing and commercializing
innovative dPCR instruments. Furthermore, dPCR has many potential applications,
including the detection and quantification of low-level pathogens, rare genetic
sequences, copy number variations (CNVs), and relative gene expression in
single cells are also key factors fuelling the demand growth of dPCR
instruments among end users.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=96291811
Key Players:
PCR technology market is
dominated by Thermo Fisher Scientific, Inc. (US), F. Hoffman-La Roche Ltd.
(Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Germany), and
Takara Bio, Inc. (Japan). Other prominent players in the market include
Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluidigm Corporation
(US)
